Harry W. Snyder

1.8k total citations · 1 hit paper
42 papers, 1.4k citations indexed

About

Harry W. Snyder is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Harry W. Snyder has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 16 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Harry W. Snyder's work include Virus-based gene therapy research (24 papers), Animal Virus Infections Studies (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Harry W. Snyder is often cited by papers focused on Virus-based gene therapy research (24 papers), Animal Virus Infections Studies (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Harry W. Snyder collaborates with scholars based in United States. Harry W. Snyder's co-authors include William D. Hardy, Evelyn E. Zuckerman, Peter Besmer, Peter J. Bergold, Erwin Fleissner, John E. Murphy, Fei-Hua Qiu, Elisabeth Stockert, E Fleissner and Frank R. Jones and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Harry W. Snyder

41 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family

1986 523 citations Harry W. Snyder, William D. Hardy et al. Nature profile →

Peers

Countries citing papers authored by Harry W. Snyder

Since Specialization

Citations

This map shows the geographic impact of Harry W. Snyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry W. Snyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry W. Snyder more than expected).

Fields of papers citing papers by Harry W. Snyder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry W. Snyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry W. Snyder. The network helps show where Harry W. Snyder may publish in the future.

Co-authorship network of co-authors of Harry W. Snyder

This figure shows the co-authorship network connecting the top 25 collaborators of Harry W. Snyder. A scholar is included among the top collaborators of Harry W. Snyder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry W. Snyder. Harry W. Snyder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma 1993 ·Cancer ·Harry W. Snyder, A Mittelman, Ayhan Oral, Gerald L. Messerschmidt, David H. Henry, S Korec, Juergen H. Bertram, Troy H. Guthrie, David Ciavarella, David Wuest, William Perkins, Joseph P. Balint, (unknown), (unknown), Frank R. Jones	83
2	Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica 1992 ·Journal of Clinical Apheresis ·Harry W. Snyder, (unknown), (unknown), Joseph P. Balint, Frank R. Jones	11
3	Use of protein A immunoadsorption as a treatment for thrombocytopenia in HIV-infected homosexual men 1991 ·AIDS ·Harry W. Snyder, Juergen H. Bertram, David H. Henry, D Kiprov, W. Barrett Benny, Abraham Mittelman, Gerald L. Messerschmidt, (unknown), William Perkins, Joseph P. Balint, Frank R. Jones	17
4	Minimal toxicity during protein a immunoadsorption treatment of malignant disease: An outpatient therapy 1991 ·Journal of Clinical Apheresis ·Harry W. Snyder, David H. Henry, Gerald L. Messerschmidt, Abraham Mittelman, Juergen H. Bertram, Edward P. Ambinder, D Kiprov, Joseph P. Balint, F. Roy MacKintosh, Max Hamburger, Michael V. Viola, John J. Fiore, James S. Louie, Donald J. Higby, Paul H. O’Brien, Sterling K. Ainsworth, Lloyd D. Fisher, William Perkins, Frank R. Jones	20
5	Reduction in Platelet‐Binding Immunoglobulins and Improvement in Platelet Counts in Patients with HIV‐Associated Idiopathic Thrombocytopenia Purpura (ITP) Following Extracorporeal Immunoadsorption of Plasma Over Staphylococcal Protein A‐Silica 1989 ·Artificial Organs ·Harry W. Snyder, Juergen H. Bertram, (unknown), (unknown), (unknown), Joseph P. Balint	24
6	Protein A Immunoadsorption Therapy in HIV‐Related Immune Thrombocytopenia: A Preliminary Report 1988 ·Artificial Organs ·Juergen H. Bertram, Harry W. Snyder, Parkash S. Gill, Ira Shulman, David H. Henry, (unknown), D Kiprov	19
7	Protein A immunoadsorption in the treatment of malignant disease. 1988 ·Journal of Clinical Oncology ·Gerald L. Messerschmidt, David H. Henry, Harry W. Snyder, Juergen H. Bertram, A Mittelman, Sterling K. Ainsworth, (unknown), M. V. Viola, (unknown), (unknown)	36
8	Prosorba^RTreatment Column: A Device that Removes Circulating Immune Complexes (CIC), IgG, and Autoimmune Antibodies From Patient Plasma 1987 ·MRS Proceedings ·Joseph P. Balint, Frank R. Jones, Harry W. Snyder	10
9	Blocking (Suppressor) Factors, Immune Complexes, and Extracorporeal Immunoadsorption in Tumor Immunity 1985 ·Karl Erik Hellström, Ingegerd Hellström, Harry W. Snyder, (unknown), Frank R. Jones	12
10	Oncoviral Proteins as Cellular Antigens 1982 ·Current topics in microbiology and immunology ·Erwin Fleissner, Harry W. Snyder	5
11	Biochemical characterization of protein kinase activities associated with transforming gene products of the Snyder-Theilen and Gardner-Arnstein strains of feline sarcoma virus 1982 ·Virology ·Harry W. Snyder	10
12	A cell surface antigen of the mouse related to xenotropic MuLv defined by naturally occurring antibody and monoclonal antibody. Relation to Gix G(rada1), G(aksl2) systems of MuLV-related antigens. 1981 ·The Journal of Experimental Medicine ·Yuuki Obata, Elisabeth Stockert, Albert B. DeLeo, Paul V. O’Donnell, Harry W. Snyder, Lloyd J. Old	17
13	Biochemical characterization of cells transformed via transfection by feline sarcoma virus proviral DNA 1981 ·Journal of Virology ·Zeda Rosenberg, Barbara G. Sahagan, Harry W. Snyder, Michael B. Worley, Max Essex, William A. Haseltine	2
14	Feline Leukemia Virus Nonproducer Lymphosarcomas of Cats as a Model for the Etiology of Human Leukemias 1981 ·Hämatologie und Bluttransfusion ·W. D. Hardy, A. J. McClelland, E Zuckerman, Harry W. Snyder, E. Gregory MacEwen, D. P. Francis, Max Essex	1
15	Relationship of the Feline Oncornavirus Associated Cell Membrane Antigen to a Feline Sarcoma Virus Encoded Polyprotein 1981 ·Hämatologie und Bluttransfusion ·Harry W. Snyder, (unknown), William D. Hardy	2
16	Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV 1980 ·Nature ·William D. Hardy, A. J. McClelland, E Zuckerman, Harry W. Snyder, E. Gregory MacEwen, D. P. Francis, Max Essex	64
17	Significance of the feline oncornavirus-associated cell-membrane antigen (FOCMA) in the natural history of feline leukemia. 1980 ·Max Essex, A. H. Sliski, Michael B. Worley, Chris K. Grant, Harry W. Snyder, W. D. Hardy, (unknown), (unknown), (unknown)	6
18	G(RADA1): a new cell surface antigen of mouse leukemia defined by naturally occurring antibody and its relationship to murine leukemia virus. 1978 ·The Journal of Experimental Medicine ·Yuuki Obata, Elisabeth Stockert, Paul V. O’Donnell, Sachie Okubo, Harry W. Snyder, Lloyd J. Old	29
19	Characterization of Molecular Species Carrying Gross Cell Surface Antigen 1977 ·Journal of Virology ·Harry W. Snyder, Elisabeth Stockert, Erwin Fleissner	74
20	Proteins specified by Sindbis virus in chick embryo fibroblast cells 1973 ·Biochemical and Biophysical Research Communications ·Harry W. Snyder, T. Sreevalsan	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact